Hong Kong Dermatology & Venereology Bulletin

Volume 10 Number 1, March 2002

Adjuvant Therapies of Pemphigus Vulgaris: A Review

Dr. W. Chan
Department of Medicine & Therapeutics, Prince of Wales Hospital, Hong Kong

Despite the reduction in mortality since the use of corticosteroids, pemphigus vulgaris still carries significant morbidity. This article reviewed recent studies on the use of available adjuvant therapies, including azathioprine, pulse cyclophosphamide, cyclosporine, methotrexate, anti-inflammatory agents, plasmapheresis, mycophenolate mofetil and intravenous immunoglobulins.

Keywords : Adjuvant therapies, pemphigus vulgaris, review

Back to Previous Page